TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -5 | -2 | 3 | 42 | 129 | 0 | 33 |
| P | %wins | 0 | 0 | 100 | 100 | 100 | 60 | ||||
| S | %ret | 1 | 1 | 1 | -5 | -2 | 3 | 42 | 129 | 0 | 33 |
| S | %wins | 100 | 100 | 0 | 0 | 0 | 40 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/7/18 16:30 | 8/6/18 | ZYNE | Zynerba Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hanlon Suzanne M. | PA | O | Sec,VP,G | P | 22 | 5.80 | 0 | 4 | 10 | 44 | D | ||||||||||||||
8/17/16 14:19 | 8/5/15 | ZYNE | Zynerba Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hanlon Suzanne M. | PA | O | Sec,GC,V | P | 54 | 17.92 | 2 | 3 | 8 | 40 | I | -71 | 57 | 44 | 38 | 26 | 1 | 1 | -5 | -2 | 3 | 42 | 129 | ||
8/17/16 14:19 | 8/16/16 | ZYNE | Zynerba Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hanlon Suzanne M. | PA | O | Sec,GC,V | S | -32 | 10.53 | 2 | -3 | -7 | 40 | I | -71 | 57 | 44 | 38 | 26 | 1 | 1 | -5 | -2 | 3 | 42 | 129 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |